Alteplase 100MG VI 1S
Ended Awarded
- Contract number
- SPE2DR26FBBLW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $61,655
Award facts
- Contract value 100% obligated
- $61,654.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $61,654.56 delivery order to Amerisourcebergen Drug Corp on June 15, 2026, for Alteplase 100MG intravenous solution. Place of performance is Conshohocken, PA. The order has a firm fixed-price structure and an ultimate completion date of June 16, 2026. No set-aside was used for this award.
Quick answers
Who was awarded contract SPE2DR26FBBLW?
SPE2DR26FBBLW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 15, 2026.
How much is contract SPE2DR26FBBLW worth?
The government has obligated $61,655 on SPE2DR26FBBLW.
Is contract SPE2DR26FBBLW an order under another contract?
Yes. SPE2DR26FBBLW is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FBBLW competed?
The extent of competition for SPE2DR26FBBLW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award